Supporting this possibility, a meta-analysis of 2878 patients with breast cancer (all subtypes) revealed that sustained FST messenger RNA (mRNA) expression correlates with prolonged recurrence-free survival compared with patients whose tumors had low FST expression (Fig. 2c). This evidence concerns the gene FST and breast carcinoma.